Impact of renal function on coronary plaque composition
肾功能对冠状动脉斑块组成的影响
基本信息
- 批准号:20790522
- 负责人:
- 金额:$ 2.66万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Young Scientists (B)
- 财政年份:2008
- 资助国家:日本
- 起止时间:2008 至 2009
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Background : Recent studies have demonstrated that patients with chronic kidney disease are at high risk of atherosclerosis. Recently, coronary plaque components can be evaluated by integrated-backscatter intravascular ultrasound (IB-IVUS) and lipid-rich plaque is associated with vulnerable plaque. This aim of the study was to investigate relationship between renal function and tissue characterization of coronary plaque composition at the target stenotic site for percutaneous coronary intervention (PCI).Methods : We prospectively performed IB-IVUS before elective PCI to 89 consecutive patients with stable angina. According to estimated glomerular filtration rate (eGFR), they were divided into the two groups (eGFR<60 ml/min/1.73m2 or eGFR≧60 ml/min/1.73m2). The tissue characteristics of the coronary plaque at each target stenotic site were evaluated by three-dimensional IB-IVUS just before PCI procedure.Results : Patients with eGFR<60 ml/min/1.73m2 had higher percentage of lipid volume and lower percentage of fibrous volume compared to patients with eGFR≧60 ml/min/1.73m2 on the 3-D IB-IVUS images (36.7±10.6% vs.28.7±9.3%, P<0.001 and 59.1±8.7% vs. 66.3±8.3%, P<0.001, respectively). eGFR showed a significant negative correlation with lipid volume and had a significant positive correlation with fibrous volume in coronary plaques(r=-0.44, p<0.0001, and r=0.46, p<0.0001, respectively)Conclusions : Impaired renal function was related to higher percentage of lipid volume and lower percentage of fibrous volume in coronary plaque. Our findings may explain the increasing risk of cardiovascular events in patients with renal dysfunction.
背景:最近的研究表明,慢性肾脏病患者是动脉粥样硬化的高危人群。近年来,积分背向散射血管内超声(IB-IVUS)可用于评价冠状动脉斑块成分,且富含脂质的斑块与易损斑块相关。本研究的目的是探讨肾功能与经皮冠状动脉介入治疗(PCI)目标狭窄部位冠状动脉斑块成分组织特征之间的关系。方法:我们在选择性PCI之前前瞻性地对89例稳定型心绞痛患者进行了IB-IVUS。根据估计肾小球滤过率(eGFR)分为eGFR<60 ml/min/1.73m2和eGFR ≥ 60 ml/min/1.73m2两组。在PCI手术前通过三维IB-IVUS评估每个靶狭窄部位的冠状动脉斑块的组织特征。在三维IB-IVUS图像上,eGFR<60 ml/min/1.73 m2的患者与eGFR> 60 ml/min/1.73 m2的患者相比,脂质体积百分比较高,纤维体积百分比较低(36.7±10.6% vs.28.7± 9.3%,P<0.001; 59.1±8.7% vs.66.3 ± 8.3%,P<0.001)。eGFR与脂质体积呈显著负相关,与斑块内纤维体积呈显著正相关(分别为r=-0.44,p <0.0001和r=0.46,p<0.0001)。结论:肾功能损害与斑块内脂质体积百分比升高和纤维体积百分比降低有关。我们的研究结果可以解释肾功能不全患者心血管事件风险增加的原因。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Plaque Burden at Left Main Coronary Artery of Patients Undergoing Percutaneous Coronary Intervention with Metabolic Syndrome.
代谢综合征患者接受经皮冠状动脉介入治疗时左主冠状动脉的斑块负担。
- DOI:
- 发表时间:2008
- 期刊:
- 影响因子:0
- 作者:Miyagi M;Ishii H;Murakami R;Isobe S;Hayashi M;Amano T;Kosuke A;Ohashi T;Uetani T;Matsubara T;Murohara T.
- 通讯作者:Murohara T.
Impact of chronic statin therapy on coronary plaque composition at angiographically severe lesions : a non-randomized study focused on history of chronic statin treatment before coronary angioplasty
慢性他汀类药物治疗对血管造影严重病变处冠状动脉斑块成分的影响:一项非随机研究,重点关注冠状动脉血管成形术前慢性他汀类药物治疗史
- DOI:
- 发表时间:2009
- 期刊:
- 影响因子:0
- 作者:Miyagi M;Ishii H;Murakami R;Isobe S;Hayashi M;Amano T;Kosuke A;Ohashi T;Uetani T;Matsubara T. Murohara T.
- 通讯作者:Matsubara T. Murohara T.
Plaque Burden at Left Main Coronary Artery of Patients Undergoing Percutaneous Coronary Intervention with Metabolic Syndrome
代谢综合征经皮冠状动脉介入治疗患者左主冠状动脉斑块负担
- DOI:
- 发表时间:2008
- 期刊:
- 影响因子:0
- 作者:Miyagi M;Ishii H;Murakami R;Isobe S;Hayashi M;Amano T;Kosuke A;Ohashi T;Uetani T;Matsubara T;Murohara T.
- 通讯作者:Murohara T.
Impact of chronic statin therapy on coronary plaque composition at angiographically severe lesions: a non-randomized study focused on history of chronic statin treatment before coronary angioplasty.
慢性他汀类药物治疗对血管造影严重病变处冠状动脉斑块成分的影响:一项非随机研究,重点关注冠状动脉血管成形术前慢性他汀类药物治疗史。
- DOI:
- 发表时间:2009
- 期刊:
- 影响因子:0
- 作者:Miyagi M;Ishii H;Murakami R;Isobe S;Hayashi M;Amano T;Kosuke A;Ohashi T;Uetani T;Matsubara T;Murohara T.
- 通讯作者:Murohara T.
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ISHII Hideki其他文献
ISHII Hideki的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ISHII Hideki', 18)}}的其他基金
Mechanical evaluation of regression and stabilization in coronary and carotid arteries by exercise therapy
通过运动疗法对冠状动脉和颈动脉的回归和稳定性进行机械评估
- 批准号:
17K09493 - 财政年份:2017
- 资助金额:
$ 2.66万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Geographical Analysis of Cesium Absorption Risk and the Recovery of Rice Cultivation in Fukushima Based on All-Bag-Inspection and Environmental Monitoring
基于全袋检查和环境监测的福岛县铯吸收风险与水稻种植恢复地理分析
- 批准号:
26870071 - 财政年份:2014
- 资助金额:
$ 2.66万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Synthesis of glycosylated derivatives of ginkgolides and in vivo evaluation of those pharmacokinetics
银杏内酯糖基化衍生物的合成及其体内药动学评价
- 批准号:
24590156 - 财政年份:2012
- 资助金额:
$ 2.66万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Relationship between renal function and composition of coronary arterial atherosclerotic plaques
肾功能与冠状动脉粥样硬化斑块成分的关系
- 批准号:
22790699 - 财政年份:2010
- 资助金额:
$ 2.66万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Syntheses of PET probes of Chinese medicinal plants, and those pharmacokinetics analysis
中药材PET探针的合成及药动学分析
- 批准号:
22790265 - 财政年份:2010
- 资助金额:
$ 2.66万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Clarification of the neuro-protective effect of ginkgolides using it's carbon-11 derivatives
利用其碳 11 衍生物阐明银杏内酯的神经保护作用
- 批准号:
20790109 - 财政年份:2008
- 资助金额:
$ 2.66万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
相似海外基金
Indication selection, patient stratification, and IND preparation for STX-002: the first-in-class LRG1 inhibitor for treatment of chronic kidney disease and immunotherapy-resistant tumours.
STX-002的适应症选择、患者分层和IND准备:用于治疗慢性肾病和免疫治疗耐药肿瘤的一流LRG1抑制剂。
- 批准号:
10092585 - 财政年份:2024
- 资助金额:
$ 2.66万 - 项目类别:
Collaborative R&D
Resident Memory T cells in Chronic Kidney Disease
慢性肾脏病中的常驻记忆 T 细胞
- 批准号:
10676628 - 财政年份:2023
- 资助金额:
$ 2.66万 - 项目类别:
Heme-mediated Mitochondrial Injury, Senescence, Acute Kidney Injury and Chronic Kidney Disease
血红素介导的线粒体损伤、衰老、急性肾损伤和慢性肾病
- 批准号:
10656648 - 财政年份:2023
- 资助金额:
$ 2.66万 - 项目类别:
The Role of Patient Capacity in Chronic Kidney Disease Trajectories
患者能力在慢性肾脏病轨迹中的作用
- 批准号:
10737920 - 财政年份:2023
- 资助金额:
$ 2.66万 - 项目类别:
Mitigating the Effects of Structural Racism on Chronic Kidney Disease Disparities among African Americans
减轻结构性种族主义对非裔美国人慢性肾病差异的影响
- 批准号:
10742680 - 财政年份:2023
- 资助金额:
$ 2.66万 - 项目类别:
Anti-Müllerian hormone and cardiovascular risk in males with chronic kidney disease: A protocol.
患有慢性肾病的男性的抗苗勒氏管激素和心血管风险:一个方案。
- 批准号:
481028 - 财政年份:2023
- 资助金额:
$ 2.66万 - 项目类别:
Effects of HIF-PHD inhibitors on copper metabolism and association with organ damage in chronic kidney disease.
HIF-PHD 抑制剂对铜代谢的影响及其与慢性肾脏病器官损伤的关系。
- 批准号:
23K15258 - 财政年份:2023
- 资助金额:
$ 2.66万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Iron homeostasis and monocyte differentiation in patients with chronic kidney disease
慢性肾病患者的铁稳态和单核细胞分化
- 批准号:
10648527 - 财政年份:2023
- 资助金额:
$ 2.66万 - 项目类别:
Acute Kidney Injury in Children with Chronic Kidney Disease
慢性肾病儿童的急性肾损伤
- 批准号:
10638267 - 财政年份:2023
- 资助金额:
$ 2.66万 - 项目类别:
Mechanisms of Mitochondrial Metabolic Dysfunction in Chronic Kidney Disease
慢性肾脏病线粒体代谢功能障碍的机制
- 批准号:
10862480 - 财政年份:2023
- 资助金额:
$ 2.66万 - 项目类别: